يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"REPOSIT study group"', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study

    المؤلفون: Bernies van der Hiel, John B.A.G. Haanen, Marcel P.M. Stokkel, Daniel S. Peeper, Connie R. Jimenez, Jos H. Beijnen, Bart A. van de Wiel, Ronald Boellaard, Alfons J.M. van den Eertwegh, REPOSIT study group

    المصدر: BMC Cancer, Vol 17, Iss 1, Pp 1-13 (2017)

    مصطلحات موضوعية: Stage IIIc/IV melanoma, Resistance, BRAF inhibitor, MEK inhibitor, 18F-FDG, 18F-FLT, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: http://link.springer.com/article/10.1186/s12885-017-3626-5Test; https://doaj.org/toc/1471-2407Test

    الوصول الحر: https://doaj.org/article/77ba6f1ed208421eb8ac731a793a38eaTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: Response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): Study protocol of a phase II, open-label, multicenter study

    المؤلفون: van der Hiel, Bernies, Haanen, John B A G, Stokkel, Marcel P M, Peeper, Daniel S., Jimenez, Connie R., Beijnen, Jos H, van de Wiel, Bart A., Boellaard, Ronald, van den Eertwegh, Alfons J M, van Tinteren, H., Wessels, Lodewyk F A, Lolkema, Martijn P J K, Hoekstra, Otto S, Hospers, Geke A P, Brouwers, Adrienne H, Koornstra, R.H.T., Arens, A. I. J., de Vos, F. Y.F.L., Hobbelink, M. G.G., Kapiteijn, H. W., de Geus-Oei, L. F., Kruit, W. H.J., Verzijlbergen, F.J., Aarts, M. J.B., Mottaghy, F. M., de Groot, J. W.B., Knollema, S., Piersma, D., Agool, A., Vreugdenhil, Art, Liem, I H, van den Berkmortel, Franchette W P J, Schreurs, M.W., REPOSIT study group

    المساهمون: MS Medische Oncologie, Cancer, UMC Utrecht, Arts-assistenten Nucleaire Geneesk.

    مصطلحات موضوعية: F-FDG, F-FLT, BRAF inhibitor, MEK inhibitor, PET/CT, Resistance, Stage IIIc/IV melanoma, Sulfonamides/administration & dosage, Melanoma/diagnostic imaging, Azetidines/administration & dosage, Piperidines/administration & dosage, Skin Neoplasms/diagnostic imaging, Humans, Drug Resistance, Neoplasm, Treatment Outcome, Positron-Emission Tomography, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Indoles/administration & dosage, Disease-Free Survival, Vemurafenib, Multicenter Studies as Topic, Neoplasm Staging, Research Design, Clinical Trials, Phase II as Topic, Genetics, Oncology, Cancer Research, Journal Article

    وصف الملف: image/pdf

    العلاقة: https://dspace.library.uu.nl/handle/1874/356417Test

    الإتاحة: https://dspace.library.uu.nl/handle/1874/356417Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث